Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
2025;306(Pt 4):141593
Semaglutide is a groundbreaking development in the field of weight loss, offering hope and effective support for individuals who have struggled to shed pounds through traditional means
Our skilled team is dedicated to personalized patient care and safe, evidence-based treatment plans
Candidates who may benefit most from beginning with the Retatrutide starting dose include those who: Have struggled with weight loss through diet and exercise alone Have metabolic conditions such as type 2 diabetes or insulin resistance Are looking for a stronger alternative to other GLP-1 medications Have a BMI of 27 or higher with at least one weight-related health condition Your prescribing physician will review your medical history and current medications before recommending the Retatrutide starting dose
The Precision Peptide Genetic Test maps genetic variants in GIPR and FTO, MC4R and 10 additional pathways affecting how your body responds to GLP-1 therapy
As an NNMT inhibitor, it is associated with reduced white adipose tissue, improved NAD+ availability, and support for insulin sensitivity
US$ 22.02
US$ 26.57
US$ 29.30
